Business Context and Reporting Period
This Form 6-K filing by Scinai Immunotherapeutics Ltd. covers the month of September 2023, with a report date of September 20, 2023. The filing primarily serves to disclose a recent capital raise event.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels. The only specific financial metric disclosed is the closing of a Registered Direct Offering totaling $1.33 million.
Material Changes
The material change reported is the successful closing of the $1.33 million Registered Direct Offering announced on September 19, 2023. No comparative financial data against prior periods is included in this specific report.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, future guidance, specific risk factors, or details on contingencies beyond the announcement of the offering closure.
Investor Verification Checklist
- Verify the final terms and share count issued in the $1.33 million Registered Direct Offering.
- Confirm the use of proceeds from the offering as detailed in the referenced press release (Exhibit 99.1).
- Review the company's most recent Form 20-F for updated liquidity and cash position following this capital raise.